AI Reconstructs Biomedical Research: MedPeer Uses AI to Break Through Efficiency Bottlenecks in the Entire Link

Currently, the integration process of AI technology and the biomedical research industry is accelerating. The industry is steadily upgrading towards intelligence, integration, and compliance. However, the long - standing pain points in the research chain have always restricted the efficiency of industrial development. From the perspective of the industry's current situation, biomedical research can be divided into two major groups: individual researchers and professional research institutions. Both groups face unavoidable development challenges, which have also given rise to a huge market demand for digital research services.

l The pain points in biomedical research are prominent, and the demand for intelligent upgrading is urgent

For individual researchers, including doctors, postgraduate students in universities, teaching teachers, and front - line research workers, they generally face problems such as cumbersome literature retrieval and organization processes, time - consuming and labor - intensive paper writing and professional drawing, high thresholds for fund project applications, and the need to frequently switch between scattered research tools. A large amount of time is consumed in non - innovative trivial matters, which directly reduces the overall research efficiency and squeezes the energy invested in core experiments and academic research.

At the institutional level, domestic medical schools in universities, top - tier hospitals, research institutes, and biomedical enterprises are also deeply trapped in the dilemma of scattered research resources, lack of standardized norms in work processes, difficulty in quality control of research results, and difficulty in improving overall research efficiency. The inability to effectively precipitate research knowledge and the low efficiency of team collaboration have become common shortcomings in the industry.

Driven by the industry's urgent needs, focusing on the pain points in the entire biomedical research chain, Beijing MedPeer Information Technology Co., Ltd. started to build the one - stop AI biomedical research operating system MedPeer in 2017. It uses intelligent products to help reduce costs and improve efficiency in biomedical research and promote high - quality innovation and development in the industry. According to the public statistics of domestic research management institutions, the number of research practitioners in the domestic biomedical field has exceeded 2 million, there are more than 3,000 relevant professional research institutions, and the number of newly added biomedical R & D projects each year exceeds 100,000. The market space for digital and intelligent empowerment in scientific research continues to expand.

l Build an AI research operating system to empower both individuals and enterprises in all scenarios

Since the project was launched in 2017, MedPeer has continuously iterated and polished its products based on the real needs of users, and completed the complete layout from the independent construction of core technologies to the implementation of full - scenario products. During the development period, the project team attached great importance to the construction of data security and compliance systems. It has successively obtained the national network security level protection level 3 certification, the triple international system certifications of ISO9001, ISO20000, and ISO27001, and completed the AI algorithm filing. It has built an enterprise - level data security protection system with complete compliance qualifications, laying the foundation for serving large - scale institutional customers.

As a new - generation AI biomedical research operating system, the core advantage of MedPeer lies in meeting the needs of the entire research scenario. It is supported by a massive and authoritative biomedical database at the bottom layer, combined with self - developed AI applications, and can meet the dual needs of individual users for lightweight use and institutional users for large - scale research empowerment.

For individual C - end users, MedPeer has set up multi - terminal usage entrances on the web and APP, and built a full - process tool matrix for topic selection, literature research, paper writing, professional drawing, academic translation, and response to review comments. Users can complete the entire set of research work without jumping between multiple platforms, realizing the reduction of the research process and the improvement of efficiency. For B - end institutional customers, the platform offers two service models: SaaS cloud deployment and private deployment. It can customize and build an exclusive research resource library, a team digital management system, and an internal knowledge precipitation platform for institutions. It can also carry out function development and brand customization according to the individual needs of institutions, filling the market gap in digital empowerment for biomedical institutions' research.

l The product implementation has achieved remarkable results, and continue to deeply cultivate the intelligent research track

After years of market implementation, MedPeer has accumulated more than 1 million real - name users in biomedicine, and has deeply served more than 5,000 professional research teams and more than 200 national - level research institutions. It is already an AI - empowered platform with a wide coverage in the domestic biomedical research field.

Judging from the actual usage feedback, MedPeer has effectively solved the high - frequency difficult problems in scientific research. After ordinary researchers use the platform, the work of literature organization and writing the first draft of a paper, which originally took three or four days, can be completed within one day, effectively freeing up the time for researchers to conduct innovative research. The research teams in top - tier hospitals can use the institution - specific research platform to systematically precipitate internal research knowledge. The efficiency of new members' project access has doubled, and the overall research output efficiency of the team has increased significantly.

The relevant person in charge of MedPeer said that the team has long adhered to the view that the core value of AI in biomedical research is to empower rather than replace. The core original intention of the project's long - term development is to use intelligent tools to separate trivial research matters and allow researchers to focus on core academic innovation. In the future, MedPeer will continue to deeply explore the needs of segmented scenarios in biomedical research, optimize the accuracy of AI tool algorithms, expand multi - scenario service capabilities, and continue to assist the digital transformation of domestic biomedical research and the implementation of scientific research innovation results.